High HBV Load Weakens Predictive Effect of Serum miR-122 on Response to Sorafenib in Hepatocellular Carcinoma Patients

BACKGROUND: MiR-122 is a liver-specific microRNA. The aim of the study was to explore the association of serum miR-122 with response to sorafenib in hepatitis B virus- (HBV-) related hepatocellular carcinoma (HCC) patients and to further reveal the effect of the virus load on such potential relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaomin, Wang, Fu'an, Gu, Guangfeng, Wu, Qingpo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214498/
https://www.ncbi.nlm.nih.gov/pubmed/34194500
http://dx.doi.org/10.1155/2021/9938207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214498/
https://www.ncbi.nlm.nih.gov/pubmed/34194500
http://dx.doi.org/10.1155/2021/9938207

Ejemplares similares